Proteon Therapeutics Garners $4,338,660 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69988c54-c071-4de0-b485-ace356868e6b - Date
2/19/2014 - Company Name
Proteon Therapeutics - Mailing Address
200 West Street Waltham, MA 02451 - Company Description
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. - Website
http://www.proteontherapeutics.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$4,338,660 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
Undisclosed
